HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monica Gatti Selected Research

phosphotyrosine phosphatase eta

9/2008Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monica Gatti Research Topics

Disease

16Neoplasms (Cancer)
12/2020 - 09/2008
5Glioblastoma (Glioblastoma Multiforme)
06/2016 - 03/2009
3Glioma (Gliomas)
11/2009 - 09/2008
2Neoplasm Metastasis (Metastasis)
12/2020 - 05/2016
2Osteosarcoma (Osteogenic Sarcoma)
01/2018 - 05/2016
2Pituitary Neoplasms (Pituitary Adenoma)
01/2013 - 03/2012
2Breast Neoplasms (Breast Cancer)
01/2013 - 01/2008
2Mesothelioma
11/2011 - 03/2010
2Tics (Tic)
10/2010 - 03/2009
1Inflammation (Inflammations)
01/2017
1Starvation
10/2016
1Prion Diseases (Transmissible Spongiform Encephalopathies)
06/2016
1Type 2 Diabetes Mellitus (MODY)
05/2016
1Carcinoma (Carcinomatosis)
04/2015
1HIV Infections (HIV Infection)
12/2013
1Rheumatoid Arthritis
12/2013
1Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2013
1Adenoma (Adenomas)
03/2012
1Malignant Mesothelioma
11/2011
1Meningioma (Meningiomas)
05/2011
1Neuroblastoma
10/2010
1Pleural Effusion (Pleural Effusions)
03/2010

Drug/Important Bio-Agent (IBA)

4Chemokine ReceptorsIBA
12/2020 - 05/2011
4Metformin (Glucophage)FDA LinkGeneric
01/2018 - 01/2013
4Pharmaceutical PreparationsIBA
01/2018 - 01/2013
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2013 - 09/2008
3LigandsIBA
01/2018 - 05/2011
3Biological ProductsIBA
01/2018 - 05/2016
3Gefitinib (Iressa)FDA Link
03/2010 - 01/2008
2Antineoplastic Agents (Antineoplastics)IBA
01/2018 - 01/2013
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2015
2ErbB Receptors (EGF Receptor)IBA
03/2009 - 01/2008
2Phosphotransferases (Kinase)IBA
03/2009 - 09/2008
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018
1Interleukin-6 (Interleukin 6)IBA
01/2017
1CytokinesIBA
01/2017
1Interleukin-8 (Interleukin 8)IBA
01/2017
1CarbohydratesIBA
10/2016
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
06/2016
1Prion ProteinsIBA
06/2016
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2015
1Alkylating AgentsIBA
01/2015
1Temozolomide (Temodar)FDA LinkGeneric
01/2015
1Hormones (Hormone)IBA
10/2014
1AdiponectinIBA
10/2014
1Growth Factor ReceptorsIBA
01/2013
1Peptide Receptors (Peptide Receptor)IBA
01/2013
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
03/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2011
1RNA (Ribonucleic Acid)IBA
10/2010
1Epidermal Growth Factor (EGF)IBA
03/2010
1Protein Tyrosine PhosphatasesIBA
11/2009
1Cytostatic AgentsIBA
11/2009
1somatostatin receptor type 1IBA
11/2009
1Caspase 3 (Caspase-3)IBA
11/2009
1BIM 23190IBA
11/2009
1TensinsIBA
03/2009
1NestinIBA
03/2009
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
03/2009
1phosphotyrosine phosphatase etaIBA
09/2008
1Somatostatin Receptors (Somatostatin Receptor)IBA
09/2008
1Estrogens (Estrogen)FDA Link
01/2008
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2008

Therapy/Procedure

6Therapeutics
01/2017 - 10/2010
2Drug Therapy (Chemotherapy)
05/2016 - 11/2011